Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioatla Inc (NQ: BCAB )

1.750 +0.010 (+0.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,716,531
Open 1.800
Bid (Size) 1.710 (9)
Ask (Size) 1.760 (75)
Prev. Close 1.740
Today's Range 1.670 - 1.906
52wk Range 1.140 - 4.020
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BCAB Stock Earnings: BioAtla Beats EPS for Q1 2024
BCAB stock results show that BioAtla beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Performance

YTD
-33.96%
-33.96%
1 Month
+12.18%
+12.18%
3 Month
-19.72%
-19.72%
6 Month
-12.50%
-12.50%
1 Year
-39.24%
-39.24%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BCAB Stock Earnings: BioAtla Beats EPS for Q4 2023
Via InvestorPlace
BioAtla: Q4 Earnings Insights
Via Benzinga
Preview: BioAtla's Earnings
Via Benzinga
Analyst Ratings for BioAtla
Via Benzinga
The Latest Analyst Ratings for BioAtla
Via Benzinga
Earnings Scheduled For March 26, 2024
Via Benzinga
Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Exposures US Equities
BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
From BioAtla, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the Jefferies London Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in Upcoming Investor Conferences in August
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
From BioAtla, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.